Transthyretin
From Proteopedia
| Line 9: | Line 9: | ||
[[1eta]], [[1ttc]], [[1tsh]], [[2trh]], [[2try]], [[1bzd]], [[1bze]], [[1fhn]], [[1g10]], [[1x7s]], [[2qel]], [[3dgd]], [[3did]], [[3kgs]] – hTTR (amyloidogenic mutant) | [[1eta]], [[1ttc]], [[1tsh]], [[2trh]], [[2try]], [[1bzd]], [[1bze]], [[1fhn]], [[1g10]], [[1x7s]], [[2qel]], [[3dgd]], [[3did]], [[3kgs]] – hTTR (amyloidogenic mutant) | ||
| + | |||
[[1ttr]] – hTTR (cardiomyapatic mutant) | [[1ttr]] – hTTR (cardiomyapatic mutant) | ||
| Line 24: | Line 25: | ||
[[1thc]], [[2h1x]], [[2h6u]] – hTTR + hydroxyaurone derivative | [[1thc]], [[2h1x]], [[2h6u]] – hTTR + hydroxyaurone derivative | ||
| + | |||
[[1tlm]] – hTTR + milrinone | [[1tlm]] – hTTR + milrinone | ||
| + | |||
[[1bm7]] – hTTR + flufenamic acid | [[1bm7]] – hTTR + flufenamic acid | ||
| + | |||
[[1dvs]], [[1dvt]], [[1dvu]], [[1dvx]], [[1dvy]], [[1dvz]], [[1tt6]], [[1tz8]], [[2f8i]], [[2fbr, [[2flm, [[2g5u]], [[2g9k]], [[2gab]], [[2qgc]], [[2qgd]], [[2qge]], [[3cn0]], [[3cn1]], [[3cn2]], [[3cn3]], [[3cn4]], [[3esn]], [[3eso]], [[3esp]], [[3glz]], [[3gs0]], [[3gs4]], [[3gs7]], [[3imr]], [[3ims]], [[3imt, [[3imu, [[3imv]], [[3imw]], [[3ipb]], [[3ipe]], [[3m10]] – hTTR + amyloid disease inhibitor | [[1dvs]], [[1dvt]], [[1dvu]], [[1dvx]], [[1dvy]], [[1dvz]], [[1tt6]], [[1tz8]], [[2f8i]], [[2fbr, [[2flm, [[2g5u]], [[2g9k]], [[2gab]], [[2qgc]], [[2qgd]], [[2qge]], [[3cn0]], [[3cn1]], [[3cn2]], [[3cn3]], [[3cn4]], [[3esn]], [[3eso]], [[3esp]], [[3glz]], [[3gs0]], [[3gs4]], [[3gs7]], [[3imr]], [[3ims]], [[3imt, [[3imu, [[3imv]], [[3imw]], [[3ipb]], [[3ipe]], [[3m10]] – hTTR + amyloid disease inhibitor | ||
| + | |||
[[1u21]], [[3cfn]], [[3cfq]], [[3cft]], [[3hj0]], [[3nee]], [[3neo]], [[3p3r]], [[3p3s]], [[3p3t, [[3p3u – hTTR + inhibitor | [[1u21]], [[3cfn]], [[3cfq]], [[3cft]], [[3hj0]], [[3nee]], [[3neo]], [[3p3r]], [[3p3s]], [[3p3t, [[3p3u – hTTR + inhibitor | ||
| + | |||
[[1e3f]], [[1e4h]], [[1e5a]], [[2b15]] – hTTR + phenol derivative | [[1e3f]], [[1e4h]], [[1e5a]], [[2b15]] – hTTR + phenol derivative | ||
| + | |||
[[2b14]], [[2b16]] – hTTR (mutant) + phenol derivative | [[2b14]], [[2b16]] – hTTR (mutant) + phenol derivative | ||
| + | |||
[[3kgt]], [[3kgu]] – hTTR (mutant) + genistein | [[3kgt]], [[3kgu]] – hTTR (mutant) + genistein | ||
| + | |||
[[3ng5]] – hTTR (mutant) + epigallocatechin gallate | [[3ng5]] – hTTR (mutant) + epigallocatechin gallate | ||
| + | |||
[[3nes]], [[3nex]] – hTTR (mutant) + inhibitor | [[3nes]], [[3nex]] – hTTR (mutant) + inhibitor | ||
| + | |||
[[1tyr]] – hTTR + retinoic acid | [[1tyr]] – hTTR + retinoic acid | ||
| + | |||
[[1kgi]] – rTTR + tetraiodotyroacetic acid | [[1kgi]] – rTTR + tetraiodotyroacetic acid | ||
| + | |||
[[1z7t]] - hTTR + tetraiodotyroacetic acid | [[1z7t]] - hTTR + tetraiodotyroacetic acid | ||
| + | |||
[[1kgj]] – rTTR + dibromoflavone | [[1kgj]] – rTTR + dibromoflavone | ||
| + | |||
[[1zcr]], [[1zd6]] – hTTR + anion | [[1zcr]], [[1zd6]] – hTTR + anion | ||
| + | |||
[[1y1d]], [[2b77]], [[2b9a]], [[3d2t]], [[3fc8]], [[3fcb]] – hTTR + diflunisal derivative | [[1y1d]], [[2b77]], [[2b9a]], [[3d2t]], [[3fc8]], [[3fcb]] – hTTR + diflunisal derivative | ||
[[3b56]] – hTTR + salicylic acid derivative | [[3b56]] – hTTR + salicylic acid derivative | ||
| Line 44: | Line 60: | ||
[[1rlb]], [[1qab]] – hTTR + RBP | [[1rlb]], [[1qab]] – hTTR + RBP | ||
| + | |||
[[2wqa]] – hTTR + RBP + oleic acid | [[2wqa]] – hTTR + RBP + oleic acid | ||
| + | |||
[[3bsz]] – hTTR + RBP + antibody | [[3bsz]] – hTTR + RBP + antibody | ||
| Line 50: | Line 68: | ||
[[2rox]], [[1ict]] – hTTR + T4 | [[2rox]], [[1ict]] – hTTR + T4 | ||
| + | |||
[[3ozk]] – hTTR (mutant) + T4 | [[3ozk]] – hTTR (mutant) + T4 | ||
| + | |||
[[1tha]], [[2roy]] – hTTR + T4 derivative | [[1tha]], [[2roy]] – hTTR + T4 derivative | ||
| + | |||
[[1ie4]] – rTTR + T4 | [[1ie4]] – rTTR + T4 | ||
| + | |||
[[1sn0]] – gsTTR + T4 | [[1sn0]] – gsTTR + T4 | ||
| + | |||
[[1sn5]] – gsTTR + T4 derivative | [[1sn5]] – gsTTR + T4 derivative | ||
Revision as of 22:41, 23 September 2011
-->
Transthyretin (TTR) is a serum carrier ot the thyroid hormone thyroxine (T4) and retinol through its association with retinol-binding protein (RBP). Many small molecules bind to TTR T4-binding site. TTR is known to be associated with amyloid diseases.
3D structures of transthyretin
2pab, 1tta, 1ttb, 1etb, 1bmz, 1f41, 1dvq, 1fh2, 1qwh, 2h4e, 2qgb, 3cbr, 3d7p, 3cfm, 3i9p, 3a4d, 3a4e, 3a4f – hTTR – human
1eta, 1ttc, 1tsh, 2trh, 2try, 1bzd, 1bze, 1fhn, 1g10, 1x7s, 2qel, 3dgd, 3did, 3kgs – hTTR (amyloidogenic mutant)
1ttr – hTTR (cardiomyapatic mutant)
1bz8, 5ttr, 1f86, 1gko, 1iii, 1iik, 1ijn, 1sok, 1soq, 1x7t, 2g3x, 2g3z, 2g4e, 2g4g, 2noy, 3bt0, 3cxf, 3djr, 3djs, 3djt, 3djz, 3dk0, 3dk2, 3do4, 3gps, 3grb, 3grg, 3i9a, 3i9i – hTTR (mutant)
1tfp – TTR – chicken
2qpf – TTR - mouse
1oo2, 1sn2 – gsTTR – gilthead seabream
1gke – rTTR – rat
TTR binary complexes
1thc, 2h1x, 2h6u – hTTR + hydroxyaurone derivative
1tlm – hTTR + milrinone
1bm7 – hTTR + flufenamic acid
1dvs, 1dvt, 1dvu, 1dvx, 1dvy, 1dvz, 1tt6, 1tz8, 2f8i, [[2fbr, [[2flm, 2g5u, 2g9k, 2gab, 2qgc, 2qgd, 2qge, 3cn0, 3cn1, 3cn2, 3cn3, 3cn4, 3esn, 3eso, 3esp, 3glz, 3gs0, 3gs4, 3gs7, 3imr, 3ims, [[3imt, [[3imu, 3imv, 3imw, 3ipb, 3ipe, 3m10 – hTTR + amyloid disease inhibitor
1u21, 3cfn, 3cfq, 3cft, 3hj0, 3nee, 3neo, 3p3r, 3p3s, [[3p3t, [[3p3u – hTTR + inhibitor
1e3f, 1e4h, 1e5a, 2b15 – hTTR + phenol derivative
2b14, 2b16 – hTTR (mutant) + phenol derivative
3kgt, 3kgu – hTTR (mutant) + genistein
3ng5 – hTTR (mutant) + epigallocatechin gallate
3nes, 3nex – hTTR (mutant) + inhibitor
1tyr – hTTR + retinoic acid
1kgi – rTTR + tetraiodotyroacetic acid
1z7t - hTTR + tetraiodotyroacetic acid
1kgj – rTTR + dibromoflavone
1y1d, 2b77, 2b9a, 3d2t, 3fc8, 3fcb – hTTR + diflunisal derivative 3b56 – hTTR + salicylic acid derivative
TTR complexes with retinol-binding potein
2wqa – hTTR + RBP + oleic acid
3bsz – hTTR + RBP + antibody
TTR complexes with thyroxine
3ozk – hTTR (mutant) + T4
1tha, 2roy – hTTR + T4 derivative
1ie4 – rTTR + T4
1sn0 – gsTTR + T4
1sn5 – gsTTR + T4 derivative
